OBJECTIVES: Computed tomography (CT) is an increasingly utilized method for the evaluation of patient suitability for transcatheter aortic valve implantation (TAVI). The aim of this study was to analyse the role of CT in the choice of prosthesis and the prevention of residual aortic regurgitation (RAR).
INTRODUCTION
Transcatheter aortic valve implantation (TAVI) is an alternative therapy for inoperable patients with aortic stenosis [1] [2] [3] . To obtain procedural success, correct patient selection is fundamental, and a particularly crucial step is the correct choice of prosthesis size, and therefore, the precise evaluation of the aortic annulus is essential. The aortic annulus is not circular and multi-detector computed tomography (MDCT) is more accurate than two-dimensional (2D) echocardiography, both transthoracic (TTE) and transoesophageal (TEE), in aortic annulus and aortic root evaluation [4] [5] [6] . TAVI presents several advantages over surgical aortic valve replacement (SAVR); however, it still shows high rates of residual aortic regurgitation (RAR) when compared with SAVR: mild paravalvular regurgitation presents with an incidence ranging from 40 to 70% in different series, whereas the incidence of more than mild aortic regurgitation varies between 7 and 20% [7, 8] . Little is still known about its determinants and about its clinical outcome, especially regarding younger patients.
A larger aortic annulus and severe calcifications of the annulus itself have already been described as being associated with residual aortic insufficiency [9] [10] [11] [12] . The purpose of this study was to further investigate the relationship between the MDCT assessment of aortic valve anatomy and RAR at discharge.
METHODS
This study retrospectively analysed 115 patients who underwent TAVI between November 2007 and September 2010. All patients underwent preoperative MDCT and TEE evaluation. A highdefinition 64-detector scanner (General Electric) was used for CT evaluation, with a retrospective gating synchronized with cardiac cycle to allow more latitude in image reconstruction. Images have been acquired during the infusion of Visipaque 320 contrast agent, and then systolic phases have been reconstructed with an ADW workstation with three-dimensional and multiplanar sections. Aortic valve, aortic root and left ventricle anatomy have been evaluated, as well as the peripheral vascular access including the entire arterial tree back to the aortic valve.
As already described by Schultz et al. [13] , the aortic annulus was measured as the aortic rim at the level where the nadir of all native leaflets could be seen in one axial view. Scrolling up on that same axial plane, we defined the cusp length as the length of the free edge of the aortic leaflets.
Standard 2D TTE and TEE provided data about the severity of the aortic stenosis and other usual anatomical and functional parameters such as ejection fraction (EF), diameters etc. These studies have been performed with a Philips iE33 (Philips, Andover, MA, USA) and a Sonos 7500 (Philips) machine, 1 or 2 days before the procedure or as a part of our outpatient TAVI screening. Before discharge, every patient underwent 2D TTE to define implant success, prosthesis positioning and RAR.
We defined the prosthesis mismatch as: ( prosthesis size − mean annulus diameter)/mean annulus diameter, which means that the value obtained is a percentage of annular dimension, taken as a benchmark. For this reason, mismatch values >0 and <0 correspond, respectively, to an oversizing and to an undersizing of the prosthesis.
Leaflet calcifications were evaluated for every cusp and were classified using a four-degree scale as: absent-trivial (0), mild (1), moderate (2) and severe (3). Total valve calcium was derived simply by adding the single results of every cusp and it was judged as absent-trivial (0-1), mild (2-3), moderate (4-6) and severe (7) (8) (9) . Annulus asymmetry was defined as a ratio of maximum to minimum diameter greater than 1.2 [14] .
We also evaluated the relationship of the position of the ascending aorta with the left ventricle using two different angles: the first is the angle between the aortic root long axis and the vertical long axis of the body (AV-A), and the second is the angle between the aortic root long axis and the left ventricle outflow tract long axis (ALVOT-A).
In addition, we evaluated by univariate analysis the association between the prosthesis mismatch and possibly related complications such as conduction abnormalities or prosthesis migration [15] .
Considering the importance of the correct fitting of the prosthesis into the aortic annulus aortic root complex and considering the structural and functional differences between the two different prostheses currently used, we analysed the overall cohort and then repeated all our analyses according to the type of prosthesis implanted.
Statistical analysis was conducted using the JMP 8.0.2 software (SAS Institute Inc., Cary, NC, USA). Continuous variables are presented as mean ± SD for data with a normal distribution or as median and inter-quantile range (IQR) for data with a non-Gaussian distribution, numbers in parenthesis denote IQR. The distribution of variables was evaluated using the one-sample Kolmogorov-Smirnov test. Categorical variables are expressed as proportions. Univariable comparisons have been performed using the un-paired t-test for parametric data and analysis of variance to evaluate the differences among more than two groups. Nominal logistic regression analysis has been selected to further evaluate the association between prosthesis/annulus mismatch (PAM) and RAR; a receiver operating characteristic (ROC) curve was used to determine the best threshold value for this correlation. Actuarial survival was calculated using the KaplanMeier curve, expressed like the percentage of survival ± confidential interval. A two-sided P-value of <0.05 was considered statistically significant.
RESULTS

Overall
Baseline and major clinical features of the patients are further described in Table 1 . Baseline clinical, procedural and MDCT characteristics analysed by RAR of the entire population are shown in Table 2 .
The median population age was 81 years (76-85), 57.4% male, median aortic valve area (AVA) 0.6 cm 2 (0.5-0.8), median EF 55% (45-60) and median logistic EuroSCORE 19.7 (11.0-32.1).
Sixty-three patients (54%) received an Edwards-SAPIEN ® prosthesis; in particular, the first 54 patients (85.7%, from November 
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2007 to July 2010) were implanted with the first-generation Edwards-SAPIEN device, whereas the following nine (14.3%, from July 2010) had a SAPIEN XT. The remaining 52 patients (45%) received a Medtronic CoreValve ReValving System ® . In-hospital mortality was 6%, and the actuarial survival at 1 year was 85.1 ± 4.3%.
Post-procedural RAR was present overall in 89 patients (78%): 55 (48%) had RAR 1+ and 34 (30%) had RAR ≥ 2+. The RAR outcome is shown in Fig. 1 .
Minimum (D min ), maximum (D max ) and mean (D med ) annulus diameters, as sized using MDCT, were, respectively, 22.6 ± 2.1 (range 19-29), 26.0 ± 2.3 (range 21-33) and 24.3 ± 2.1 mm (range 20-30); they all were significantly associated with RAR (P = 0.0113, P = 0.0003 and P = 0.0010, respectively).
Mean D max /D min was 1.15 ± 0.07 and annular asymmetry was found in 28.7% of all patients, but it did not appear to be associated with RAR (P = 0.91). Moderate to severe aortic leaflet calcifications were present in 108 patients (93.9%), with an asymmetric pattern in 11 (9.6%), but no significant association was observed with RAR regarding location (cusp involvement), global severity (P = 0.95) or asymmetry (P = 0.86). The length of the free edge of the valve leaflets (mean 24.5 ± 2.3 mm) was also significantly related to RAR (P = 0.0007) and to the mean diameter (P < 0.0001). No significant association was observed between RAR and aortic root inclination with respect to the left ventricle: P = 0.50 and P = 0.67 for AV-A and ALVOT-A, respectively. PAM, as measured by MDCT, had a mean value of 8.9 ± 9% (range 31 to −13%) and was significantly associated with RAR (P = 0.0006).
Logistic regression analysis between the CT mismatch and RAR was significant (P = 0.0004), and the ROC curve showed an area under the curve (AUC) of 0.70, with a mismatch cut-off level of 0.074 associated with the highest sensitivity and specificity of 70 and 62%, respectively.
No association was found between the prosthesis mismatch and possible adverse events, such as atrio-ventricular block (AVB, P = 0.9) or need for a second valve (P = 0.7), as shown in Table 3 .
Edwards subgroup
The Edwards group's baseline features are reported in Table 1 and assessment of the association with RAR in Table 4 .
No significant differences could be appreciated between the two subgroups, except for a larger use of a 26-mm diameter prosthesis in the Edwards group (41 vs. 16 patients, P = 0.0002) and a larger AVA in the CoreValve group (0.7 ± 0.1, P = 0.0026). In the Edwards group, the association between the mismatch and RAR became stronger (P < 0.0001). Moreover, CT asymmetry measured as D max /D min reached the limit of significance (P = 0.02), even if annulus asymmetry assessed as a nominal variable did not (P = 0.17). Logistic regression analysis between the mismatch and RAR showed a significant association (P < 0.0001), and the ROC curve found the best mismatch cut-off value of 0.019 (AUC 0.83, 79% sensitivity, 71% specificity).
In the Edwards subgroup, only one patient had an intraprocedural AVB (mismatch −0.13), five required in-hospital PM implantation (no mismatch association, P = 0.53), one required an immediate second valve implantation due to severe RAR (mismatch 0.0) and no one suffered prosthesis embolization.
Direct comparisons between the Edwards and the CoreValve group are shown in Table 5 .
CoreValve subgroup
The CoreValve group's baseline features are reported in Table 1 and association with RAR in Table 6 . There were no significant associations when analysing the CoreValve patients alone, although some parameters nearly reached the significance level (D med P = 0.08 and D max P = 0.07).
Associations between ALVOT-A and RAR showed a difference in that RAR appeared more frequent when the long axis of the aortic root diverged more from the left ventricle outflow tract (LVOT) long axis, but this did not appeared statistically significant (P = 0.30).
Logistic regression and ROC curve analyses between the CT mismatch and RAR showed a mismatch cut-off value of 0.11 (P = 0.1614, AUC 0.65, 73% sensitivity, 65% specificity).
No association was found between the mismatch and any of the possible mismatch complications such as intraprocedural and in-hospital AVB (respectively, P = 0.39 and P = 0.35) or prosthesis embolization (P = 0.96).
The results of logistic regression analyses and the ROC curve of the whole sample and of the two prosthesis subgroups are listed in Table 7 .
CoreValve patients showed a trend towards larger annular diameters (P = 0.07 for both D max and D med ) and presented a greater prosthesis oversizing (mean Edwards mismatch 0.04 ± 0.07, mean CoreValve mismatch 0.14 ± 0.08, P < 0.0001).
All patients who suffered a prosthesis embolization/migration (three patients) had received a CoreValve (P = 0.0275).
Other direct comparisons between the Edwards and the CoreValve groups are shown in Table 5 .
DISCUSSION
Correct annular sizing remains a fundamental step for a successful percutaneous valve implantation procedure. We did not find any significant association between baseline (e.g. male sex), clinical (e.g. peripheral arteriopathy) or procedural (e.g. types of prosthesis) features and RAR [7] . Using a variety of techniques 
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(echocardiography, MDCT, angiography), many parameters have already been related to RAR, particularly large annulus dimensions, PAM, valve calcifications, LVOT-ascending aorta angle and depth of prosthesis implantation. In our series, using preoperative MDCT, we observed an association between annulus diameters and early RAR, particularly for mean (P = 0.0010) and maximum (P = 0.0003) diameters, such that questions may be raised as to whether the maximum diameter may be the better parameter to take into consideration.
We also found a significant direct association between mean annulus diameter and mean cusp length, respectively, 24.3 ± 2.1 and 24.5 ± 2.3 (P < 0.0001). These parameters seem to vary with a precise 1:1 ratio and this could be a useful tool in the setting of low CT image quality, e.g. in patients with atrial fibrillation, when measuring the minimum and maximum diameters may not always be simple and accurate.
Other authors like Schultz et al. [14] and Détaint et al. [16] have already pointed out the importance of the PAM regarding RAR and therefore the importance of adequate prosthesis oversizing, respectively, in a self-expandable prosthesis series and in a balloon-expandable prosthesis series. In our population, mean CT PAM was 9%, with a pretty wide range (from 31 to −13%), and it was significantly inversely associated with RAR (P = 0.0006): indeed, a positive value of mismatch represents an oversizing whereas a negative value represents an undersizing.
ROC curve analysis found a mismatch cut-off level of 7.4% at which the test had 70% sensitivity and 62% specificity. Thus, we can say that, in general, an insufficient oversizing under 7% increases the probability of significant RAR and therefore the choice of a prosthesis's nominal size should never exactly match the annulus size, but that a small and significant oversizing should always be done (e.g. 1.75 mm oversizing for a 25-mm annulus). This is consistent with the work already published by Détaint et al. [16] , that reported no patient with significant RAR (≥2) when the 'cover index' was >8%, calculated as 100 × ( prosthesis diameter − TEE annulus diameter/prosthesis diameter).
Moreover, in our series, the Edwards and CoreValve prostheses showed a different level of mismatch to avoid significant RAR, and in particular for the Edwards prosthesis, just 2% oversizing may be sufficient, whereas the CoreValve prosthesis seems to need a larger oversizing up to 11.5%; although statistical significance for the CoreValve group was not reached. Actually, although the Edwards is suitable for a small annulus, the CoreValve is usually used on a larger annulus and that has to be taken into consideration.
Evaluating a CoreValve prosthesis population through the angiographic assessment, Sherif et al. [17] observed a significant association between RAR and the increasing angle of LVOT to the ascending aorta (they also generated a predictive model using this parameter in conjunction with the depth of prosthesis implantation in relation to the non-coronary cusp). Utilizing MDCT, we too observed in our CoreValve subgroup a difference in this angle (ALVOT-A) between patients with and without RAR, with increasing RAR for the increasing angulation of the aortic root axis from the LVOT axis, although this difference did not appear statistically significant in our analyses (P = 0.30).
We did not find any significant association between annular calcification and RAR, in terms of location in regard to cusp involvement, global severity (P = 0.95) or asymmetry (P = 0.86).
Most annuli were not circular, but an important difference between D max and D min was only observed in 33 patients (28.7%), and it did not appear to influence RAR when analysing together the 115 patients (P = 0.91). Considering only the patients who had an Edwards implantation, we observed a significant inverse relation between the D max /D min and RAR > 1 (P = 0.02); this may imply that annular asymmetry may be more important for the Edwards than for the CoreValve and may be actually in agreement with the possibility of the CoreValve System to conform to the annular dimensions when the annulus is not circular as reported by Schultz et al. [18] . However, more data are required before this conclusion can be reached.
Analysis of the CoreValve group showed no significant association between any of the CT-assessed parameters and RAR. In part, this may be related to the fact that the CoreValve group had an important oversizing (mean 14%), due to the intrinsic larger prosthesis size available and the common practice of 'always oversizing', so that in the end a certain loss of significance may happen.
Furthermore, an important limitation of this study is that the depth of implantation was not investigated and this could be an important factor for the CoreValve prosthesis that appears in our experience to be more challenging and less precise to correctly deploy. In our series, although correct prosthesis positioning was not evaluated, it is interesting that all three patients who suffered a prosthesis embolization/migration had received a CoreValve.
No evident association was found between the prosthesis mismatch and complications such as AVB (P = 0.9) or need for a second valve (P = 0.7), neither assessed as the whole sample or separately by the type of prosthesis. However, no definite conclusion can be drawn from this analysis because of the small 
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N. Buzzatti et al. / European Journal of Cardio-Thoracic Surgerynumber of cases studied and more experience must be gained given the complex anatomy of the aortic root and the risk of potential complications at that level [19, 20] . Collaterally, we observed that intraprocedural atrio-ventricular conduction anomalies and in-hospital PM implantation were much more frequent with the CoreValve prosthesis [21, 22] than with the Edwards prosthesis (P = 0.0061 and P = 0.04, respectively): actually, the PM implantation rate was 7.9% (5 of 63) and 21.2% (11 of 52) in the Edwards and Corevalve subgroups, respectively.
Other important limitations of this study must be underlined: it is a retrospective analysis with a small number of patients, and it lacks a comparison with echocardiography in terms of sizing precision and RAR prediction, which is an important issue that needs to be addressed in the future. Moreover, it does not take into consideration the exact location of the RAR and its association with the CT imaging. Finally, follow-up data will be fundamental in verifying the role of CT in RAR prediction and in RAR evolution.
However, given the high predictive power of MDCT regarding RAR, especially using annulus diameter, mean cusp length and PAM measures, we think MDCT should be the gold standard and a primary step in TAVI preoperative planning.
Considering the association between RAR and large annulus dimensions and PAM as well as the lack of evidence of an association between a moderate (up to 20%) prosthesis oversizing and possible complications such as conduction abnormalities, we support the common practice of routine oversizing of the prosthesis. We discourage implantation of a prosthesis of the same nominal diameter of the aortic annulus as measured by MDCT.
CONCLUSIONS
RAR is significantly associated with larger annular diameters, larger leaflet free-edge length and less PAM ( prosthesis undersizing or insufficient oversizing). Oversizing the prosthesis by at least 7% can significantly help in reducing the risk of RAR, possibly without any additional risk; moreover, the different prostheses may need a different oversizing.
MDCT showed a good predictive power for RAR and remains the preferred technique to evaluate the aortic root in TAVI planning.
Have you always used a CT scan in your centre, since the beginning of your experience in 2007, to choose the correct prosthesis?
Dr Buzzatti: We didn't do it in the beginning, but it is routine right now. For the last two years we have routinely done a preoperative CT scan in every patient, and we assess the annulus dimensions, the peripheral access and everything else that could be of interest.
Dr Bruschi: Analysing your experience retrospectively, do you evaluate whether, in the patients for whom you chose the size of the valve on the basis of echo (transoesophageal or transthoracic), you would have chosen the same size valve on the basis of the CT scan measurement, or whether you would have chosen a different size of valve?
Dr Buzzatti: Retrospectively, we are analysing what we have done. Probably we would have implanted a larger prosthesis, because the echo tends to underestimate the dimension of the annulus. We didn't include the echo data in the presentation because they weren't complete. But we definitely rely more on the CT scan.
Dr Bruschi: Do you perform any correlation between the annulus measurement on CT scan and echo? I mean, do you evaluate whether the dimension of the annulus on CT scan, mean diameter and maximal diameter, correlates with the dimension of the annulus on echo?
Dr Buzzatti: Actually, it is not a precise correlation. There is a sort of tendency of the echo to underestimate the mean annulus by almost 3 mm, but it is not a direct relation between the minimum CT diameter and the maximum diameter of the echo.
Dr Bruschi: My last question. Do you consider only the diameter or do you also to try to calculate the circumference of the annulus?
Dr Buzzatti: It depends on the quality of the images. We can use all three methods. It depends on the quality. Basically we use the mean diameter and the length of the free edge of the cusps, these two.
Dr A. Van Linden (Bad Nauheim, Germany): I have one simple question. Was the 29 mm Edwards valve available at that time, or did you just implant 23 and 26 mm for the Edwards valve?
Dr Buzzatti: The 29 mm was not then available. Dr Van Linden: Because your conclusion was the larger the annulus, the more regurgitation, and I think with a 29 mm valve maybe some patients would have received the larger valve.
Dr Buzzatti: Yes, of course, but it wasn't available.
Dr N. Moat (London, UK): I think we are all trying to move into more precise definitions. You say that you classified the severity of calcification. How did you define the severity of calcification?
Dr Buzzatti: We assessed the calcification regarding the severity, the position, and the asymmetry. We didn't use Agaston scores or other scores that other groups have used, but we defined the severity using a simple visual scale from one to three, leaflet by leaflet, and then giving the sum of the three leaflets. We didn't observe any association with residual aortic regurgitation. Actually, though not presented here, we found association with one-year residual aortic regurgitation, but, again, we didn't have all the follow-up data.
Dr Moat: I think that's interesting, because there are some data suggesting that the volume and density of calcification is related to paravalvular aortic regurgitation. Have you got any comment why your data seems to differ from those data?
Dr Buzzatti: I am not sure of the reason. Probably other groups have utilized other methods that may be more precise than the one we used. But calcification is not the only parameter to take into account for the correct deployment of the prosthesis, and, of course, the precision of the deployment, depth of implantation, are very important, and then you have to take into consideration the fact that the CoreValve has the ability to conform to the annulus while the Edwards is small, stiff and more rigid and is more difficult.
Dr Moat: I think that is a good answer. Perhaps we need to look at more specific ways of quantifying volume and density of calcification rather than just a crude grading from 1 to 3.
Dr O. Wendler (London, UK): I have one other question. You mentioned the accuracy of your CT assessment. Has that resulted in the fact that you don't use TOE at all anymore? How do you see intraoperative TOE or the value of intraoperative TOE in this context? Dr Buzzatti: We use the echo for the assessment of all the clinical and functional data that are necessary before or during interventions. But for the size of the prosthesis, we rely on the CT scan, definitely.
Dr Moat: One final question. Given that you have demonstrated that oversizing the Sapien prosthesis reduces paravalvular regurgitation, have you changed your sizing strategy in your unit to deliberately oversize the Edwards valve?
Dr Buzzatti: Yes, we have taken to the habit of always oversizing the prosthesis, of course, and, yes, all the evaluations of the CT scan changed our way of approaching a TAVI.
